product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
BACH1/BRIP1 Antibody
catalog :
4578
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
reactivity :
human
application :
western blot
citations: 4
Published Application/Species/Sample/DilutionReference
  • western blot; human
He X, Zhang P. Serine/arginine-rich splicing factor 3 (SRSF3) regulates homologous recombination-mediated DNA repair. Mol Cancer. 2015;14:158 pubmed publisher
  • western blot; human; 1:1000; fig 7
Simpson D, Lemonie N, Morgan D, Gaddameedhi S, Kaufmann W. Oncogenic BRAF(V600E) Induces Clastogenesis and UVB Hypersensitivity. Cancers (Basel). 2015;7:1072-90 pubmed publisher
  • western blot; human
Choi Y, Pan Y, Park E, Konstantinopoulos P, De S, D ANDREA A, et al. MicroRNAs down-regulate homologous recombination in the G1 phase of cycling cells to maintain genomic stability. elife. 2014;3:e02445 pubmed publisher
  • western blot; human
Savage K, Gorski J, Barros E, Irwin G, Manti L, Powell A, et al. Identification of a BRCA1-mRNA splicing complex required for efficient DNA repair and maintenance of genomic stability. Mol Cell. 2014;54:445-59 pubmed publisher
product information
SKU :
4578S
Product-Name :
BACH1/BRIP1 Antibody
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H
Applications :
Western blot
Product-Category :
Cell Cycle / Checkpoint Control
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
145
Host :
Rabbit
Target :
BRIP1
Primary-Protein :
BRIP1
Alt-Names :
ATP-dependent RNA helicase BRIP1,BACH1,BRCA1 interacting protein C-terminal helicase 1,BRCA1-associated C-terminal helicase 1,BRCA1-binding helicase-like protein BACH1,BRCA1-interacting protein 1,BRCA1-interacting protein C-terminal helicase 1,BRIP1,FANCJ,FLJ90232,Fanconi anemia group J protein,MGC126521,MGC126523,OF,Protein FACJ
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.